A drug demonstrating anxiolytic effect based on hydrogenated pyrido (4, 3-B) indoles, its pharmacological compound and application method

Details for Australian Patent Application No. 2008271026 (hide)

Owner Medivation Neurology, Inc.

Inventors Bachurin, Sergey Olegovich; Grigoriev, Vladimir Viktorovich

Agent Pizzeys

Pub. Number AU-A-2008271026

PCT Pub. Number WO2009/005771

Priority 2007124175 28.06.07 RU

Filing date 27 June 2008

Wipo publication date 8 January 2009

International Classifications

A01N 43/38 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/405 (2006.01)

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/005771 Priority application(s): WO2009/005771

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008271033-Multi-channel controller

2008271014-Method and system for monitoring tissue during an electrosurgical procedure